Natasha Kyprianou, PhD, MBBS

1. Doxazosin induces apoptosis of benign and malignant prostate epithelial cells via a death receptor mediated pathway. Garrison JB and Kyprianou N. Cancer Res 66:464-472, 2006.
2. Novel quinazoline-based compounds impair prostate tumorigenesis by targeting tumor vascularity Garrison JB, Shaw Y-J, Chen C-S and Kyprianou N. Cancer Res 67(23):11344-11352, 2007.
3. Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Sakamoto S, McCann RO, Dhir R and Kyprianou N. Cancer Res 70(5):1885-1895, 2010.
4. Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells. Zhu M and Kyprianou N. The FASEB Journal 24(3):769-777, 2010.
5. Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer. Zhu M, Horbinski C, Garzotto M, Qian D, Beer T and Kyprianou N. Cancer Res 70(20):7992-8002, 2010.

Cancer Center Member

Research Focus

Programs

• Molecular and Cellular Oncology

College & Department

• College of Medicine
• Department of Surgery

Insurance Information

Insurance policies can vary widely. Please check with your doctor/clinic for specific insurance information before your visit or procedure to avoid unexpected out-of-pocket costs. See list of insurers